Table 1.
Group | Mice (n) | Treatment | Route | Positive (%) | Mean score* |
---|---|---|---|---|---|
1 | H-2/hIL-6 (8) | Extract 1 | i.v. | 3 (37.5) | 3+ |
2 | H-2/hIL-6 (6) | Extract 2 | i.v. | 2 (33.3) | 4+ |
3 | H-2/hIL-6 (7) | Extract 3 | i.v. | 6 (85.7) | 1.9+ |
4 | H-2/hIL-6 (5) | PBS | i.v. | 0 (0) | 0 |
5 | H-2/hIL-6 (7) | Extract 4 | i.v. | 7 (100) | 3.1+ |
6 | MT-1/hIL-6 (8) | Extract 4 | Gavage | 5 (62.5) | 4+ |
7 | MT-1/hIL-6 (7) | Extract 5 | i.v. | 5 (71.4) | 4+ |
8 | H-2/hIL-6 (9) | Extract 5/cooked | i.v. | 5 (55.6) | 1.75+ |
9 | H-2/hIL-6 (6) | Extract 5/guanidine HCl | i.v. | 2 (33.3) | 0.5+ |
10 | BALB/c (10) | Extract 5 | i.v. | 8 (80) | 1.6+ |
11 | BALB/c (5) | PBS | i.v. | 0 (0) | 0 |
*Mean score of amyloid-positive spleens in each group.